The epidemiology of skin cancer in organ transplant recipients

Skin Disease in Organ Transplantation

Volumn , Issue , 2008, Pages 142-146

  Lindelöf, Bernt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956989680     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511547379.025     Document Type: Chapter

References (40)

1. Walder B, Robertson M, Jeremy D. Skin cancer and immuno-suppression. Lancet 1971;2:1282.
2. Adami J, Gäbel H, Lindelöf B, et al. Cancer risk following organ transplantation: a nation-wide cohort study in Sweden. Br J Cancer 2003;89:1221–7.
3. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries 1964–1986. Int J Cancer 1995;60:183–9.
4. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177–86.
5. Harvelt M, Bouwes-Bavinck J, Koote J, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506–09.
6. Lindelöf B, Sigurgeirsson B, Gäbel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Brit J Der-matol 2000;143:513–9.
7. Hollenbeak CS, Todd MM, Billingsley EM, et al. Increased incidence of melanoma in renal transplantation recipients. American Cancer Society 2005;104:1962–7.
8. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005;80:s254–s264.
9. Moloney FJ, Comber H, O’lorcain P et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154:498–504.
10. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681–91
11. Lindelöf B, Jarnvik J, Ternesten-Bratel A et al. Mortality and clinico-pathologic features of cutaneous squamous cell carcinoma in organ transplant recipients.: A study of the Swedish cohort. Acta Derm Venereol 2006;86(3):219–22, 2006.
12. Lindelöf B, Dal H, Wolk K, Malmborg N. Cutaneous cell carcinoma in organ transplant recipients: A study of the Swedish cohort with regard to tumor site. Arch Dermatol 2005;141:447–51.
13. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000;7:147–56.
14. Ramsay HM, Fryer AA, Hawley CM et al. Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003;49:397–406.
15. Lindelöf B, Granath F, Dal H et al. Sun habits in kidney transplant recipients with skin cancer: A case control study of possible causative factors. Acta Derm Venereol 2003;83:189–93.
16. Otley CC, Coldiron BM, Stasko T et al. Decreased skin cancer after cessation of the therapy with transplant-associated immunosuppres-sants. Arch Dermatol 2001;137:459–63.
17. Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factor in a Spanish Mediterranean population of kidney transplant recipients. Brit J Dermatol 2003;149: 1221–6.
18. Naldi L, Fortina AB, Lovati S et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000;70:1479–84.
19. Bordea C, Wojnarowska F, Millard PR et al. Skin cancer in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574–79.
20. Bouwes-Bavinck J, Hardie D, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996;61:715–721.
21. Ong C, Keogh A, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999;40:27–34.
22. Moosa MR. Kaposi’s sarcoma in kidney transplant recipients: a 23-year experience. Q J Med 2005;98:205–14.
23. Woodle E, Hanaway M, Buell J, et al. Kaposi’s sarcoma. An analysis of the US and international experiences from the Israel Penn international transplant tumor registry. Transplant Proc 2001;33: 3660–1.
24. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995;60:1485–91.
25. Penn I, First MR. Merkel’s cell carcinoma in organ transplant recipients: report of 41 cases. Transplantation 1999;68:1717–21.
26. Berg D, Otley CC. Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1–17.
27. Gjersvik P, Hansen S, Moller B et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 2000;13(Suppl. 1)5380–1.
28. Ulrich C, Schmook T, Sachse MM et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004;30:622–7.
29. Belloni Fortina A, Caforio AL, Piaserico S et al. Skin cancer in heart transplant recipients: Frequency and risk factor analysis. J Heart Lung Transplant 2000;19:249–55.
30. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemi-ologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995;33:222–9.
31. Otley CC, Pittelkow MR. Skin cancer in liver transplant recipients. Liver Transpl 2000;6:253–62.
32. Herrero JI, Espana A, Quiroga J et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transpl 2005;11: 1100–6.
33. Euvrard S, Kanitakis J, Cochat P, Claudy A. Skin cancers following pediatric organ transplantation. Dermatol Surg 2004;30:616–21.
34. Coutinho HM, Groothoff JW, Offringa M et al. De novo malignancy after pediatric renal replacement therapy. Arch Dis Child 2001;85:478–83.
35. Penn I. De novo malignancy in pediatric organ transplant recipients. Pediatr transplant 1998;2:56–63.
36. Moosa MR. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine 2005;84: 12–22.
37. Hoshida Y, Aozasa K. Malignancies in organ transplant recipients. Pathology International 2004;54:649–58.
38. Hsu R-B, Chen RJ, Chou N-K et al. Low incidence of malignancy after transplantation in Chinese heart allograft recipients. Transplant Int 2005;18:283–8.
39. Caforio AL, Fortina AB, Piaserico S et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosup-pressive therapy. Circulation 2000;103:3222–27.
40. Moloney FJ, Kelly PO, Kay EW, Conlon P, Murphy GM. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 2004;30:674–8.